120 related articles for article (PubMed ID: 38926676)
1. Association between COVID-19 convalescent plasma antibody levels and COVID-19 outcomes stratified by clinical status at presentation.
Park H; Yu C; Pirofski LA; Yoon H; Wu D; Li Y; Tarpey T; Petkova E; Antman EM; Troxel AB;
BMC Infect Dis; 2024 Jun; 24(1):639. PubMed ID: 38926676
[TBL] [Abstract][Full Text] [Related]
2. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.
Joyner MJ; Carter RE; Senefeld JW; Klassen SA; Mills JR; Johnson PW; Theel ES; Wiggins CC; Bruno KA; Klompas AM; Lesser ER; Kunze KL; Sexton MA; Diaz Soto JC; Baker SE; Shepherd JRA; van Helmond N; Verdun NC; Marks P; van Buskirk CM; Winters JL; Stubbs JR; Rea RF; Hodge DO; Herasevich V; Whelan ER; Clayburn AJ; Larson KF; Ripoll JG; Andersen KJ; Buras MR; Vogt MNP; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Paneth NS; Fairweather D; Wright RS; Casadevall A
N Engl J Med; 2021 Mar; 384(11):1015-1027. PubMed ID: 33523609
[TBL] [Abstract][Full Text] [Related]
3. Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis.
Troxel AB; Petkova E; Goldfeld K; Liu M; Tarpey T; Wu Y; Wu D; Agarwal A; Avendaño-Solá C; Bainbridge E; Bar KJ; Devos T; Duarte RF; Gharbharan A; Hsue PY; Kumar G; Luetkemeyer AF; Meyfroidt G; Nicola AM; Mukherjee A; Ortigoza MB; Pirofski LA; Rijnders BJA; Rokx C; Sancho-Lopez A; Shaw P; Tebas P; Yoon HA; Grudzen C; Hochman J; Antman EM
JAMA Netw Open; 2022 Jan; 5(1):e2147331. PubMed ID: 35076699
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.
Park H; Tarpey T; Liu M; Goldfeld K; Wu Y; Wu D; Li Y; Zhang J; Ganguly D; Ray Y; Paul SR; Bhattacharya P; Belov A; Huang Y; Villa C; Forshee R; Verdun NC; Yoon HA; Agarwal A; Simonovich VA; Scibona P; Burgos Pratx L; Belloso W; Avendaño-Solá C; Bar KJ; Duarte RF; Hsue PY; Luetkemeyer AF; Meyfroidt G; Nicola AM; Mukherjee A; Ortigoza MB; Pirofski LA; Rijnders BJA; Troxel A; Antman EM; Petkova E
JAMA Netw Open; 2022 Jan; 5(1):e2147375. PubMed ID: 35076698
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
6. Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV-2 IgG antibodies compared to blood group A donations.
Hayes C; Rubenstein W; Gibb D; Klapper E; Tanaka J; Pepkowitz S
Transfusion; 2021 Aug; 61(8):2245-2249. PubMed ID: 34036595
[TBL] [Abstract][Full Text] [Related]
7. Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.
Park HS; Yin A; Barranta C; Lee JS; Caputo CA; Sachithanandham J; Li M; Yoon S; Sitaras I; Jedlicka A; Eby Y; Ram M; Fernandez RE; Baker OR; Shenoy AG; Mosnaim GS; Fukuta Y; Patel B; Heath SL; Levine AC; Meisenberg BR; Spivak ES; Anjan S; Huaman MA; Blair JE; Currier JS; Paxton JH; Gerber JM; Petrini JR; Broderick PB; Rausch W; Cordisco ME; Hammel J; Greenblatt B; Cluzet VC; Cruser D; Oei K; Abinante M; Hammitt LL; Sutcliffe CG; Forthal DN; Zand MS; Cachay ER; Raval JS; Kassaye SG; Marshall CE; Yarava A; Lane K; McBee NA; Gawad AL; Karlen N; Singh A; Ford DE; Jabs DA; Appel LJ; Shade DM; Lau B; Ehrhardt S; Baksh SN; Shapiro JR; Ou J; Na YB; Knoll MD; Ornelas-Gatdula E; Arroyo-Curras N; Gniadek TJ; Caturegli P; Wu J; Ndahiro N; Betenbaugh MJ; Ziman A; Hanley DF; Casadevall A; Shoham S; Bloch EM; Gebo KA; Tobian AA; Laeyendecker O; Pekosz A; Klein SL; Sullivan DJ
JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38483534
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia.
Bar KJ; Shaw PA; Choi GH; Aqui N; Fesnak A; Yang JB; Soto-Calderon H; Grajales L; Starr J; Andronov M; Mastellone M; Amonu C; Feret G; DeMarshall M; Buchanan M; Caturla M; Gordon J; Wanicur A; Monroy MA; Mampe F; Lindemuth E; Gouma S; Mullin AM; Barilla H; Pronina A; Irwin L; Thomas R; Eichinger RA; Demuth F; Luning Prak ET; Pascual JL; Short WR; Elovitz MA; Baron J; Meyer NJ; Degnan KO; Frank I; Hensley SE; Siegel DL; Tebas P
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34788233
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.
Ortigoza MB; Yoon H; Goldfeld KS; Troxel AB; Daily JP; Wu Y; Li Y; Wu D; Cobb GF; Baptiste G; O'Keeffe M; Corpuz MO; Ostrosky-Zeichner L; Amin A; Zacharioudakis IM; Jayaweera DT; Wu Y; Philley JV; Devine MS; Desruisseaux MS; Santin AD; Anjan S; Mathew R; Patel B; Nigo M; Upadhyay R; Kupferman T; Dentino AN; Nanchal R; Merlo CA; Hager DN; Chandran K; Lai JR; Rivera J; Bikash CR; Lasso G; Hilbert TP; Paroder M; Asencio AA; Liu M; Petkova E; Bragat A; Shaker R; McPherson DD; Sacco RL; Keller MJ; Grudzen CR; Hochman JS; Pirofski LA; ; Parameswaran L; Corcoran AT; Rohatgi A; Wronska MW; Wu X; Srinivasan R; Deng FM; Filardo TD; Pendse J; Blaser SB; Whyte O; Gallagher JM; Thomas OE; Ramos D; Sturm-Reganato CL; Fong CC; Daus IM; Payoen AG; Chiofolo JT; Friedman MT; Wu DW; Jacobson JL; Schneider JG; Sarwar UN; Wang HE; Huebinger RM; Dronavalli G; Bai Y; Grimes CZ; Eldin KW; Umana VE; Martin JG; Heath TR; Bello FO; Ransford DL; Laurent-Rolle M; Shenoi SV; Akide-Ndunge OB; Thapa B; Peterson JL; Knauf K; Patel SU; Cheney LL; Tormey CA; Hendrickson JE
JAMA Intern Med; 2022 Feb; 182(2):115-126. PubMed ID: 34901997
[TBL] [Abstract][Full Text] [Related]
10. Distinct SARS-CoV-2 antibody reactivity patterns in coronavirus convalescent plasma revealed by a coronavirus antigen microarray.
Assis R; Jain A; Nakajima R; Jasinskas A; Khan S; Davies H; Corash L; Dumont LJ; Kelly K; Simmons G; Stone M; Di Germanio C; Busch M; Felgner PL
Sci Rep; 2021 Apr; 11(1):7554. PubMed ID: 33824382
[TBL] [Abstract][Full Text] [Related]
11. High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients.
Greenbaum U; Klein K; Martinez F; Song J; Thall PF; Ramdial JL; Knape C; Aung FM; Scroggins J; Knopfelmacher A; Mulanovich V; Borjan J; Adachi J; Muthu M; Leung C; Medina MC; Champlin R; Olson A; Alousi A; Rezvani K; Shpall EJ
Front Immunol; 2021; 12():675679. PubMed ID: 33995420
[TBL] [Abstract][Full Text] [Related]
12. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program.
Wendel S; Kutner JM; Machado R; Fontão-Wendel R; Bub C; Fachini R; Yokoyama A; Candelaria G; Sakashita A; Achkar R; Hamerschlak N; Scuracchio P; Amaral M; Dal Ben M; Araujo D; Soares C; Camargo A; Kallás E; Durigon E; Reis LF; Rizzo LV
Transfusion; 2020 Dec; 60(12):2938-2951. PubMed ID: 32935877
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC.
Yoon HA; Bartash R; Gendlina I; Rivera J; Nakouzi A; Bortz RH; Wirchnianski AS; Paroder M; Fehn K; Serrano-Rahman L; Babb R; Sarwar UN; Haslwanter D; Laudermilch E; Florez C; Dieterle ME; Jangra RK; Fels JM; Tong K; Mariano MC; Vergnolle O; Georgiev GI; Herrera NG; Malonis RJ; Quiroz JA; Morano NC; Krause GJ; Sweeney JM; Cowman K; Allen S; Annam J; Applebaum A; Barboto D; Khokhar A; Lally BJ; Lee A; Lee M; Malaviya A; Sample R; Yang XA; Li Y; Ruiz R; Thota R; Barnhill J; Goldstein DY; Uehlinger J; Garforth SJ; Almo SC; Lai JR; Gil MR; Fox AS; Chandran K; Wang T; Daily JP; Pirofski LA
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33476300
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.
Yokoyama APH; Wendel S; Bonet-Bub C; Fachini RM; Dametto APF; Blumm F; Dutra VF; Candelaria GTP; Sakashita AM; Machado RRG; Fontão-Wendel R; Hamerschlak N; Achkar R; Assunção MSC; Scuracchio P; Nudelman V; Pastore L; Pinho JRR; Ben MD; Filho RK; Marra AR; Amano MT; Kallás EG; Helito AS; de Carvalho CRR; Araujo DB; Durigon EL; Camargo AA; Rizzo LV; Reis LFL; Kutner JM
Transfusion; 2021 Aug; 61(8):2295-2306. PubMed ID: 34173248
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
16. Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection.
Clark NM; Janaka SK; Hartman W; Stramer S; Goodhue E; Weiss J; Evans DT; Connor JP
PLoS One; 2022; 17(3):e0257930. PubMed ID: 35259162
[TBL] [Abstract][Full Text] [Related]
17. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
18. Convalescent plasma in hospitalized pediatric and obstetric coronavirus disease 2019 (COVID-19) patients.
Ikeda S; Benzi E; Hensch LA; Devaraj S; Hui SR; Gandhi M; Fox KA; Teruya J; Munoz FM
Pediatr Int; 2022 Jan; 64(1):e15407. PubMed ID: 36326636
[TBL] [Abstract][Full Text] [Related]
19. Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry.
De Silvestro G; Marson P; La Raja M; Cattelan AM; Guarnieri G; Monticelli J; Tiberio I; Vianello A; Gandini G; Gessoni G; Fiorin F; Sardella C; Astolfi L; Saia M;
Eur J Intern Med; 2022 Mar; 97():42-49. PubMed ID: 34980505
[TBL] [Abstract][Full Text] [Related]
20. Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial.
Bégin P; Callum J; Heddle NM; Cook R; Zeller MP; Tinmouth A; Fergusson DA; Cushing MM; Glesby MJ; Chassé M; Devine DV; Robitalle N; Bazin R; Shehata N; Finzi A; McGeer A; Scales DC; Schwartz L; Turgeon AF; Zarychanski R; Daneman N; Carl R; Amorim L; Gabe C; Ellis M; Sachais BS; Loftsgard KC; Jamula E; Carruthers J; Duncan J; Lucier K; Li N; Liu Y; Armali C; Kron A; Modi D; Auclair MC; Cerro S; Avram M; Arnold DM
Trials; 2021 May; 22(1):323. PubMed ID: 33947446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
